Tumour ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma

scientific article published on 01 December 1998

Tumour ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/QJMED/91.12.821
P698PubMed publication ID10024947

P2093author name stringR Williams
S R Shah
S M Riordan
J Karani
P433issue12
P921main subjecthepatocellular carcinomaQ1148337
decompensated cirrhosisQ109887496
P304page(s)821-828
P577publication date1998-12-01
P1433published inQJM: An International Journal of MedicineQ7265477
P1476titleTumour ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma
P478volume91

Reverse relations

cites work (P2860)
Q95841166Feasibility of Automated Volumetric Assessment of Large Hepatocellular Carcinomas' Responses to Transarterial Chemoembolization
Q33253330Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT).
Q36140437Predictors of hepatic decompensation after TACE for hepatocellular carcinoma
Q37283698Safety and efficacy of transcatheter arterial chemoemboliazation in the real-life management of unresectable hepatocellular carcinoma
Q39562856Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells.

Search more.